Prostate Cancer Vaccine Wins OK
A new vaccine called Provenge has just been accepted by the FDA, making it the first to be approved by the agency for men fighting advanced prostate cancer. While Provenge is not a cure, it has shown promise in extending the lives of patients.
A new vaccine called Provenge has just been accepted by the FDA, making it the first to be approved by the agency for men fighting advanced prostate cancer. While Provenge is not a cure, it has shown promise in extending the lives of patients.
The treatment won’t come cheap, however, at $93,000 per patient. –JCL
Rock Solid JournalismThe BBC:
A “vaccine” which harnesses the body’s own immune system to fight prostate cancer has been approved for use by US drug regulators.
Provenge — which is designed to be used in men with advanced disease — is the first of its kind to be accepted by the Food and Drug Administration.
Each dose has to be individually tailored and it is an expensive treatment at $93,000 per patient.
It will add to, rather than replace, existing treatments, said experts.
In 2026, amid chaos and the nonstop flurry of headlines, Truthdig remains independent, fact-based and focused on exposing what power tries to hide.
Support Independent Journalism.
Health & Wellness
Scientists say chemicals in everything from food packaging to bath products cause lasting health damage and call for urgent global action.
Editorial Cartoons
Editorial Cartoons
Visit Ann Telnaes’ Substack Open Windows for more.
Health & Wellness
Frequent exposure to plastic chemicals — especially through food packaging — makes potential impacts more concerning, say researchers.
Editorial Cartoons
Film
Cinema’s most striking colorist paints a scene from the end of life.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.